Regentis Biomaterials
Latest round
- Series D
Last raised
- Feb 2016
Total raised
- $33M
Investors
- 8
About Regentis Biomaterials
Regentis Biomaterials Ltd.Founded in 2004 in Or Akiva, Israel, Regentis Biomaterials specializes in hydrogel solutions for orthopedic tissue repair., Ltd.Regentis Biomaterials primarily focuses on the development of GelrinC, a resorbable hydrogel designed for orthopedic applications to assist in tissue repair. GelrinC provides a supportive matrix, promoting cellular infiltration and regeneration.The company generates revenue through B2B sales of GelrinC implants to healthcare institutions involved in orthopedic surgeries. Their pricing aligns with industry standards, and they maintain relationships with medical professionals to secure ongoing supply agreements. The company is actively seeking to introduce new products and enhance its geographical footprint in additional markets by targeting specific regions for expansion.
Who invested in Regentis Biomaterials
8 investors across 3 rounds
See all investors in Regentis Biomaterials
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Regentis Biomaterials
Who invested in Regentis Biomaterials?
Regentis Biomaterials has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Regentis Biomaterials raised?
Regentis Biomaterials has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Regentis Biomaterials last raise money?
Regentis Biomaterials's most recent round on record is a Series D, in Feb 2016.
What does Regentis Biomaterials do?
Regentis Biomaterials is a materials company.
Where is Regentis Biomaterials headquartered?
Regentis Biomaterials is headquartered in Or Akiva, Israel.
Which VCs invest in companies like Regentis Biomaterials?
Among active investors with capital left to deploy, Hui Hua Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back materials companies at Regentis Biomaterials's stage. Their profiles are linked below.
VCs backing materials startups at Series D
Raising like Regentis Biomaterials? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.